Patient safety associated with the surgical treatment of bone and soft tissue tumours during the COVID-19 pandemic—results from an observational study at the Oxford Sarcoma Service
<p><strong>Purpose</strong></p> <p>Deferring cancer surgery can have profound adverse effects including patient mortality. During the COVID-19 pandemic, departmental reorganisation and adherence to evolving guidelines enabled provision of uninterrupted surgical care to...
Main Authors: | Rajasekaran, RB, Kotecha, S, Whitwell, D, Cosker, TDA, Critchley, P, Fries, CA, Pigott, D, Gibbons, CLMH, Carr, A |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Springer
2020
|
Similar Items
-
Service delivery during the COVID-19 pandemic: experience from the Oxford Bone Tumour and Soft Tissue Sarcoma service
by: Rajasekaran, RB, et al.
Published: (2020) -
Surgical management of primary bone sarcomas
by: Cosker, TDA, et al.
Published: (2021) -
Will virtual multidisciplinary team meetings become the norm for musculoskeletal oncology care following the COVID-19 pandemic? Experience from a tertiary sarcoma centre.
by: Rajasekaran, R, et al.
Published: (2021) -
The role of intraoperative cell salvage for musculoskeletal sarcoma surgery
by: Rajasekaran, RB, et al.
Published: (2021) -
What proportion of patients with bone and soft tissue tumors contracted coronavirus-19 and died from surgical procedures during the initial period of the COVID-19 pandemic? results from the multicenter British Orthopaedic Oncology Society Observational Study
by: Rajasekaran, RB, et al.
Published: (2020)